Lunai Bioworks Inc.
LNAI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $37,634 | $22,233 | $12,829 | $11,976 |
| - Cash | $93 | $220 | $1,874 | $9,172 |
| + Debt | $10,173 | $3,787 | $5,594 | $7,016 |
| Enterprise Value | $47,715 | $25,799 | $16,548 | $9,821 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$129 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$177,153 | -$85,869 | -$38,864 | -$112,937 |
| % Margin | – | – | – | – |
| Net Income | -$178,007 | -$88,426 | -$39,684 | -$113,433 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.78 | -9.1 | -7.1 | -21.6 |
| % Growth | -18.5% | -28.2% | 67.1% | – |
| Operating Cash Flow | -$7,875 | -$10,971 | -$11,775 | -$15,732 |
| Capital Expenditures | -$0 | -$70 | -$30 | -$5 |
| Free Cash Flow | -$7,875 | -$11,042 | -$11,804 | -$15,737 |